Document Detail

Post-menopausal hormone replacement therapy and stroke risk.
MedLine Citation:
PMID:  10997775     Owner:  NLM     Status:  MEDLINE    
This paper will review available data bearing on the relationship of post-menopausal hormone replacement therapy to the risk of first or recurrent ischaemic stroke. Although experimental data from both human and animal studies will be briefly mentioned, the bulk of evidence is from observational epidemiological studies. As such, the limitations of observational studies, particularly as applied to the health effects of post-menopausal hormone replacement therapy, will be emphasized. We conclude that there is no compelling consistent evidence that post-menopausal hormone replacement therapy either decreases or increases stroke risk. There are, however, reasons to be concerned that this therapy may contribute to stroke risk.
S J Kittner; M G Bousser
Related Documents :
9871405 - Is the free androgen index a useful clinical marker in male patients?
21860025 - Impact of gene expression profiling-based risk stratification in patients with myeloma ...
15249765 - Coronary heart disease risk reduction in postmenopausal women: the role of statin thera...
2562605 - Transdermal oestrogen for postmenopausal women: a double blind crossover comparative st...
11477495 - Relationship of a large weight loss to long-term weight change among young and middle-a...
7285575 - Factors associated with family planning acceptance in bangkok metropolis health clinic ...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Review    
Journal Detail:
Title:  Cephalalgia : an international journal of headache     Volume:  20     ISSN:  0333-1024     ISO Abbreviation:  Cephalalgia     Publication Date:  2000 Apr 
Date Detail:
Created Date:  2001-01-25     Completed Date:  2001-01-26     Revised Date:  2008-02-11    
Medline Journal Info:
Nlm Unique ID:  8200710     Medline TA:  Cephalalgia     Country:  NORWAY    
Other Details:
Languages:  eng     Pagination:  208-13     Citation Subset:  IM    
Department of Neurology, University of Maryland School of Medicine, Baltimore, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Arteriosclerosis / epidemiology,  prevention & control
Cardiovascular Diseases / epidemiology,  prevention & control
Estrogen Replacement Therapy / adverse effects*,  methods
Hemostasis / drug effects
Risk Factors
Selection Bias
Stroke / chemically induced*,  epidemiology
Thrombosis / chemically induced,  epidemiology

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pharmacodynamics of oestrogens and progestogens.
Next Document:  Interstitial colocalization of two cervid satellite DNAs involved in the genesis of the Indian muntj...